Pascal and Francis Bibliographic Databases


Search results

Your search



A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 12810

  • Page / 513

Selection :

  • and

Interactions of Doxorubicin with Organized Interfacial Assemblies. 2. Spectroscopic CharacterizationNIECIECKA, Dorota; KROLIKOWSKA, Agata; SETIAWAN, Iwan et al.Langmuir. 2013, Vol 29, Num 47, pp 14570-14579, issn 0743-7463, 10 p.Article

Early detection of doxorubicin-induced myocardial damage by ultrasound tissue characterization with integrated backscatterYOKOYAMA, Naoyuki; TAKESHITA, Satoshi; KOZUMA, Ken et al.Circulation journal. 2003, Vol 67, Num 11, pp 929-933, issn 1346-9843, 5 p.Article

Fabrication of double-walled microspheres for the sustained release of doxorubicinENG CHEW TAN; RONGYI LIN; WANG, Chi-Hwa et al.Journal of colloid and interface science. 2005, Vol 291, Num 1, pp 135-143, issn 0021-9797, 9 p.Article

Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity : Translational ProteomicsGRATIA, Séverine; KAY, Laurence; MICHELLAND, Sylvie et al.Journal of proteomics (Print). 2012, Vol 75, Num 15, pp 4705-4716, issn 1874-3919, 12 p.Article

Doxorubicin-derived metabolites induce release of cytochrome c and inhibition of respiration on cardiac isolated mitochondriaCLEMENTI, Maria Elisabetta; GIARDINA, Bruno; DI STASIO, Enrico et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2445-2450, issn 0250-7005, 6 p.Article

Deregulation of gene expression in fetal oocytes exposed to doxorubicinBONILLA, Edmundo; DEL MAZO, Jesus.Biochemical pharmacology. 2003, Vol 65, Num 10, pp 1701-1707, issn 0006-2952, 7 p.Article

Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell linesSERPE, Loredana; GUIDO, Marilena; EANDI, Mario et al.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 3062-3069, issn 1533-4880, 8 p.Article

Interactions of Doxorubicin with Organized Interfacial Assemblies. 1. Electrochemical CharacterizationNIECIECKA, Dorota; JONIEC, Aleksandra; BLANCHARD, G. J et al.Langmuir. 2013, Vol 29, Num 47, pp 14560-14569, issn 0743-7463, 10 p.Article


Magic ferritin : A novel chemotherapeutic encapsulation bulletSIMSEK, Ece; KILIC, Mehmet Akif.Journal of magnetism and magnetic materials. 2005, Vol 293, Num 1, pp 509-513, issn 0304-8853, 5 p.Conference Paper

Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cellsDONGZHI WEI; YUYING MEI; JIANWEN LIU et al.Biotechnology letters. 2003, Vol 25, Num 4, pp 291-294, issn 0141-5492, 4 p.Article

Repetitive doxorubicin treatment of glioblastoma enhances the PGP expression: a special role for endothelial cellsRITTIERODT, Marion; HARADA, Kunyu.Experimental and toxicologic pathology (Print). 2003, Vol 55, Num 1, pp 39-44, issn 0940-2993, 6 p.Article

Unravelling molecular mechanisms in the fluorescence spectra of doxorubicin in aqueous solution by femtosecond fluorescence spectroscopyCHANGENET-BARRET, Pascale; GUSTAVSSON, Thomas; MARKOVITSI, Dimitra et al.PCCP. Physical chemistry chemical physics (Print). 2013, Vol 15, Num 8, pp 2937-2944, issn 1463-9076, 8 p.Article

Combination efficacy of doxorubicin and adenoviral methioninase gene therapy with prodrug selenomethionineGUPTA, Anshu; MIKI, Kenji; MINGXU XU et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1181-1188, issn 0250-7005, 8 p.Article

Binding and Encapsulation of Doxorubicin on Smart Pectin Hydrogels for Oral DeliveryBOSIO, Valeria E; MACHAIN, Victoria; GOMEZ LOPEZ, Azucena et al.Applied biochemistry and biotechnology. 2012, Vol 167, Num 5, pp 1365-1376, issn 0273-2289, 12 p.Article

Actualités Caelyx® : actualités ASCO 2003 = Caelyx® : news (ASCO 2003)SPANO, J. P.La Lettre du cancérologue (Boulogne). 2003, Vol 12, Num 4, pp 3-6, issn 1165-113X, 4 p., SUPArticle

Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicityLU FAN; GOH, Boon-Cher; IAU, Philip et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 7, pp 621-629, issn 1744-6872, 9 p.Article

Reversible Derivatization to Enhance Enzymatic Synthesis : Chemoenzymatic Synthesis of Doxorubicin-14-O-EstersCOTTERILL, Ian C; RICH, Joseph O; SCHOLTEN, Marc D et al.Biotechnology and bioengineering. 2008, Vol 101, Num 3, pp 435-440, issn 0006-3592, 6 p.Article

Identification and characterization of the afsR homologue regulatory gene from Streptomyces peucetius ATCC 27952PARAJULI, Niranjan; HUNG TRINH VIET; ISHIDA, Kenji et al.Research in microbiology (Paris). 2005, Vol 156, Num 5-6, pp 707-712, issn 0923-2508, 6 p.Article

Chronic cardiotoxicity of anticancer anthracyclines in the rat: Role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivitySACCO, Giuseppe; GIAMPIETRO, Rossella; MINOTTI, Giorgio et al.British journal of pharmacology. 2003, Vol 139, Num 3, pp 641-651, issn 0007-1188, 11 p.Article

Characterization and in vitro cytotoxicity of doxorubicin-loaded γ-polyglutamic acid-chitosan composite nanoparticlesHELLMERS, Frank; FERGUSON, Peter; KOROPATNICK, James et al.Biochemical engineering journal. 2013, Vol 75, pp 72-78, issn 1369-703X, 7 p.Article

Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathwayHONG, Hong-Jye; LIU, Ju-Chi; CHEN, Po-Yuan et al.International journal of cardiology. 2012, Vol 157, Num 2, pp 174-179, issn 0167-5273, 6 p.Article

Proteomic analysis of doxorubicin-induced changes in the proteome of HepG2cells combining 2-D DIGE and LC-MS/MS approachesHAMMER, Elke; BIEN, Sandra; GESELL SALAZAR, Manuela et al.Proteomics (Weinheim. Print). 2010, Vol 10, Num 1, pp 99-114, issn 1615-9853, 16 p.Article

Porous silicon as drug carrier for controlled delivery of doxorubicin anticancer agentVACCARI, Lisa; CANTON, Davide; ZAFFARONI, Nadia et al.Microelectronic engineering. 2006, Vol 83, Num 4-9, pp 1598-1601, issn 0167-9317, 4 p.Conference Paper

Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude miceHSIN MING YANG; REISFELD, R. A.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 4, pp 1189-1193, issn 0027-8424Article

  • Page / 513